Pharma-Bio Serv (PBSV) Net Income Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 9.01% |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 74.75% |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 156.91% |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | -14.58% |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | - |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 35.73% |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | -16.63% |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 40.29% |
| 10 | Pharma-Bio Serv | - | - | 722,374.00 | -57.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -57.45% |
| Oct 31, 2025 | -26.00% |
| Jul 31, 2025 | -39.97% |
| Apr 30, 2025 | -26.49% |
| Jan 31, 2025 | -69.65% |
| Oct 31, 2024 | 26.06% |
| Jul 31, 2024 | -28.78% |
| Apr 30, 2024 | -42.44% |
| Jan 31, 2024 | -44.39% |
| Oct 31, 2023 | -32.51% |
| Jul 31, 2023 | -8.73% |
| Apr 30, 2023 | -16.20% |
| Jan 31, 2023 | -6.81% |
| Oct 31, 2021 | -239.05% |
| Jul 31, 2021 | 536.76% |
| Apr 30, 2021 | 58.84% |
| Jan 31, 2021 | 50.34% |
| Oct 31, 2020 | 17.03% |
| Jul 31, 2020 | 84.17% |
| Apr 30, 2020 | 60.44% |
| Jan 31, 2020 | 50.06% |
| Oct 31, 2018 | -36.86% |
| Jul 31, 2018 | -73.13% |
| Apr 30, 2018 | -32.64% |
| Jan 31, 2018 | -38.64% |
| Jul 31, 2017 | -31.48% |
| Apr 30, 2017 | -43.98% |
| Jan 31, 2017 | -37.11% |
| Oct 31, 2016 | -34.27% |
| Jul 31, 2016 | -28.15% |
| Apr 30, 2016 | -70.07% |
| Jan 31, 2016 | -30.73% |
| Oct 31, 2015 | -21.37% |
| Jul 31, 2015 | -29.14% |
| Apr 30, 2015 | -32.89% |
| Jan 31, 2015 | -36.88% |
| Jul 31, 2014 | -26.42% |
| Apr 30, 2014 | -11.92% |
| Jan 31, 2014 | 22.94% |
| Oct 31, 2013 | 88.12% |
| Jul 31, 2013 | 117.34% |